44 results on '"Smith, Emma M."'
Search Results
2. Technology and human occupation
3. Development of Priority Assistive Product Lists in Three African Countries.
4. Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosis
5. The Kenyan assistive technology ecosystem: a network analysis
6. Exploring equity and inclusion in Malawi’s National Disability Mainstreaming Strategy and Implementation Plan
7. Developing a Holistic Process to Measure Assistive Technology Outcomes.
8. Empirical research and available data on assistive technology for persons with disabilities in Malawi: A review
9. Walking Aid Use in Canada: Prevalence and Demographic Characteristics Among Community-Dwelling Users
10. Relevance of assistive technology and the sustainable development goals to stakeholder organizations in Malawi
11. Schlafen2 is a regulator of quiescence in adult murine hematopoietic stem cells
12. Prevalence of wheelchair and scooter use among community-dwelling Canadians
13. Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma
14. Network analysis of assistive technology stakeholders in Malawi
15. Socio-Demographic Factors Influencing the Use of Assistive Technology among Children with Disabilities in Malawi
16. An overview of assistive technology products and services provided in Malawi
17. Assistive Technology Use and Provision During COVID-19: Results From a Rapid Global Survey
18. COVID-19 as social disability: the opportunity of social empathy for empowerment
19. Implementation of the Assistive Product List (APL) in Malawi through development of appropriate policy and systems: an action research protocol
20. Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma
21. Socio-Demographic Factors Influencing the Use of Assistive Technology among Children with Disabilities in Malawi
22. Successful gene therapy of Diamond-Blackfan anemia in a mouse model and human CD34+ cord blood hematopoietic stem cells using a clinically applicable lentiviral vector
23. Assistive Technology Use and Provision During COVID-19: Results From a Rapid Global Survey.
24. Assistive Technology Use and Provision During COVID-19: Results From a Rapid Global Survey
25. Implementation of the Assistive Product List (APL) in Malawi through development of appropriate policy and systems: an action research protocol
26. COVID-19 as social disability: the opportunity of social empathy for empowerment
27. Measuring met and unmet assistive technology needs at the national level: Comparing national database collection tools across eight case countries
28. Feasibility RCT protocol evaluating a powered-wheelchair training program for older adults
29. Reliability and responsiveness of the Self-Efficacy in Assessing, Training and Spotting wheelchair skills (SEATS) outcome measure
30. Enabling appropriate personnel skill-mix for progressive realization of equitable access to assistive technology
31. Assistive technology policy: a position paper from the first global research, innovation, and education on assistive technology (GREAT) summit
32. Simultaneous targeted activation of Notch1 and Vhl-disruption in the kidney proximal epithelial tubular cells in mice
33. Needs for mobility devices, home modifications and personal assistance among Canadians with disabilities.
34. The combination of HDAC and aminopeptidase inhibitors is highly synergistic in myeloma and leads to disruption of the NFκB signalling pathway
35. Characterization of a Novel Mouse Model of Multiple Myeloma and Its Use in Preclinical Therapeutic Assessment
36. A Novel Mouse Model of Multiple Myeloma Representative of Human Disease and Its Use in Preclinical Therapeutic Assessment
37. Hypermethylation Is A Key Feature of the Transition of Multiple Myeloma to Plasma Cell Leukemia
38. Global Methylation Array Analysis of Multiple Myeloma Samples Indicate An Alteration of Epigenetics During the Transition From MGUS to Myeloma and An Increased Frequency of Gene Methylation in t(4;14) Myeloma.
39. Inhibition of HDACs and Aminopeptidases Is Highly Synergistic in Myeloma Cells Resulting in Cell Death Via the Upregulation of BIRC3, a Key Mediator of NF-KappaB Signalling.
40. Aminopeptidase inhibition as a targeted treatment strategy in myeloma
41. Inhibition of EBF function by active Notch signaling reveals a novel regulatory pathway in early B-cell development
42. Successful gene therapy of Diamond-Blackfan anemia in a mouse model and human CD34 + cord blood hematopoietic stem cells using a clinically applicable lentiviral vector.
43. Correction of pathology in mice displaying Gaucher disease type 1 by a clinically-applicable lentiviral vector.
44. The combination of HDAC and aminopeptidase inhibitors is highly synergistic in myeloma and leads to disruption of the NFκB signalling pathway.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.